Rectal Neoplasms: all 1,804 studies
Page 18 of 19. Open to participants first (520), then studies with results posted, then the rest; newest registration first within each.
- Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal CancersCompletedNCT00410579
- Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum CancerCompletedNCT00409994Phase 1/2
- Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal CancerCompletedNCT00403624Phase 1/2
- Comparative Study of Circular Stapling InstrumentsTerminatedNCT00399009Not applicable
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CATerminatedNCT00394615Not applicable
- Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal CancerStatus unknownNCT00392470Phase 1
- Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer TrialCompletedNCT00386828Phase 2
- Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal CancerStatus unknownNCT00383695Phase 2
- Partnership for Healthy SeniorsCompletedNCT00379743Not applicable
- Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal AdenocarcinomaTerminatedNCT00353457Phase 2
- Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal CancerCompletedNCT00349076Phase 3
- Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the RectumWithdrawnNCT00346099Phase 2
- Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By SurgeryCompletedNCT00336960Phase 2
- Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal CancerActive, not recruitingNCT00335816Phase 2
- Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and CTerminatedNCT00309517Phase 3
- Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00303771Phase 3
- COLOR II: Laparoscopic Versus Open Rectal Cancer RemovalCompletedNCT00297791Phase 3
- Preoperative Chemoradiation With Capecitabine and CetuximabCompletedNCT00297128Phase 2
- Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal CancerCompletedNCT00296608Phase 3
- Liver Transplantation and Metastatic Colo-rectal Cancer.Active, not recruitingNCT00294827Phase 2
- Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation TherapyCompletedNCT00280761
- Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal CancerCompletedNCT00280176Phase 1
- Oxaliplatin and 5-FU Based Preoperative ChemoradiationCompletedNCT00278694Phase 2
- Peritoneal Microdialysis in Patients Undergoing Low Anterior Resection (LAR) for Recto-sigmoid CancerCompletedNCT00271986
- Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal CancerCompletedNCT00263029Phase 2
- Oxaliplatin in Rectal CancerTerminatedNCT00259363Phase 1/2
- Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal CancerStatus unknownNCT00254683Phase 2
- A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal PatientsTerminatedNCT00254436Phase 3
- Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal CancerCompletedNCT00238381Phase 3
- Clinical Trial in Patients With Metastatic Colorectal CancerCompletedNCT00235898Phase 2
- Preoperative Combined Radiation and Chemotherapy - Rectal CancerCompletedNCT00232453Phase 2
- Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal CancerCompletedNCT00227747Phase 3
- Prospective Study in Pelvic Radiotherapy PatientsCompletedNCT00220181
- A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal CancerCompletedNCT00220051Phase 2
- A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal CarcinomaCompletedNCT00215956Phase 1
- Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal AdenocarcinomaTerminatedNCT00207831Phase 3
- Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.Status unknownNCT00199277Phase 4
- Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)CompletedNCT00190541Phase 3
- 5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal CancerStatus unknownNCT00189657Phase 3
- Quality Initiative in Rectal Cancer (QIRC) TrialStatus unknownNCT00182130Not applicable
- Radiation Therapy With Capecitabine in Rectal CancerTerminatedNCT00176787Phase 2
- CORE: Capecitabine, Oxaliplatin, Radiotherapy and ExcisionCompletedNCT00174616Phase 2
- Oral Topotecan As A Radiosensitizing Agent In Rectal CancerTerminatedNCT00158886Phase 1
- Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal CancerStatus unknownNCT00154752Phase 3
- A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of RectumCompletedNCT00145769Phase 3
- Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsCompletedNCT00138177Phase 1
- TNFerade™ Plus Chemo/Radiation/Surgery for Rectal CancerCompletedNCT00137878Phase 2
- Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00134069Phase 1
- A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal CancerStatus unknownNCT00122291Phase 2
- Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal CancerCompletedNCT00102011Phase 3
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
- Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal CancerTerminatedNCT00088933Phase 1
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
- Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00086931Phase 1/2
- Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal CancerCompletedNCT00084773Not applicable
- GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid TumorsCompletedNCT00084643Phase 1
- Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00084591Phase 1
- Clinical Trial in Patients With Metastatic Colorectal CancerCompletedNCT00081627Phase 2
- Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal CancerCompletedNCT00077298Phase 2
- Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal CancerCompletedNCT00075868Phase 3
- Study Evaluating EKB-569 in Advanced Colorectal CancerCompletedNCT00072748Phase 2
- Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal CancerTerminatedNCT00070265Phase 2
- Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal CancerTerminatedNCT00070122Phase 3
- Study Evaluating MAC-321 in Colorectal CancerCompletedNCT00063427Phase 2
- A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerCompletedNCT00060411Phase 1
- Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal CancerStatus unknownNCT00058474Phase 3
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.CompletedNCT00056459Phase 3
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00056446Phase 3
- Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerTerminatedNCT00052585Phase 2
- Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal CancerCompletedNCT00052559Phase 1
- Safety Study of hMN14 to Treat Either Colorectal or Breast CancerCompletedNCT00041652Phase 1/2
- Imatinib Mesylate in Treating Patients With Stage IV Colorectal CancerCompletedNCT00041340Phase 2
- Safety Study of 90Y-hMN14 to Treat Colorectal CancerCompletedNCT00040599Phase 1/2
- Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by SurgeryCompletedNCT00036400Phase 3
- Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00032110Phase 2
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
- Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT00026234Phase 2
- Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedCompletedNCT00025337Phase 3
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal CancerCompletedNCT00023933Phase 1
- Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal CancerCompletedNCT00023751Phase 2
- Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal CancerCompletedNCT00021398Phase 2
- Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00020267Phase 1
- Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the LiverCompletedNCT00019760Phase 2
- Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerCompletedNCT00019006Phase 1
- Comparison of Two Types of Surgery in Treating Patients With Rectal CancerStatus unknownNCT00007930Phase 3
- Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00006366Phase 2
- Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00006094Phase 1/2
- SU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerCompletedNCT00005818Phase 1/2
- Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove PolypsCompletedNCT00005094Phase 3
- Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00005036Phase 3
- Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionCompletedNCT00004911Phase 1/2
- PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During SurgeryCompletedNCT00004891Not applicable
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
- Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal CancerCompletedNCT00003873Phase 3
- Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00003799Phase 1
- Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically RemovedCompletedNCT00003422Phase 3
- SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to FluorouracilCompletedNCT00003254Phase 2